Publication | Closed Access

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

Hematological MalignancyValproic AcidMedicineMixed-phenotype Acute LeukemiaHematologyPharmacologyPhase 2Adult T-cell Leukemia-lymphomaOncologyAll-trans Retinoic AcidCancer ResearchMyeloid Neoplasia